Guy's Hospital in London has become one of the first NHS institutions to offer Wegovy, a weight-loss jab that reduces appetite by mimicking fullness hormones.
The drug Wegovy, also known as Ozempic, is prescribed to patients with a BMI over 35, potentially benefiting around 3.4 million adults in the UK.
Professor Barbara McGowan highlighted the significant demand for Wegovy, estimating around 130,000 eligible patients in southeast London who could benefit from this treatment.
Ray, a patient who weighed 23 stone, has been prioritized for weight loss treatment due to his need for two necessary operations and expressed positive feelings about the progress.
Collection
[
|
...
]